GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:19151749
Citation |
Zhou, Q and Geahlen, RL (2009) The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells. Oncogene 28:1348-56 |
---|---|
Abstract |
The nonreceptor, protein-tyrosine kinase Syk is a suppressor of breast cancer progression whose expression is inversely correlated with the invasive behavior of cancer cells. In contrast, Syk has a positive function in murine mammary tumor virus-mediated tumorigenesis. A yeast two-hybrid screen using a library from human mammary gland identified tumor necrosis factor (TNF) receptor-associated factor-interacting protein (TRIP) as an Syk-binding partner. This interaction is mediated by the C-terminal region of TRIP and is enhanced by the treatment of cells with TNF and the tyrosine phosphorylation of Syk. Syk and TRIP have opposing functions in TNF-signaling pathways. Syk enhances the activation of nuclear factor-kappaB by TNF and this is antagonized by TRIP. The overexpression of TRIP sensitizes cells to TNF-induced apoptosis, an effect that can be reversed by the coexpression of Syk. |
Links |
PubMed PMC2656405 Online version:10.1038/onc.2008.493 |
Keywords |
Breast Neoplasms/metabolism; Breast Neoplasms/pathology; Cell Line, Tumor; Female; Humans; Immunoprecipitation; Intracellular Signaling Peptides and Proteins/physiology; NF-kappa B/metabolism; Phosphorylation; Protein-Tyrosine Kinases/physiology; TNF Receptor-Associated Factor 2/physiology; Tumor Necrosis Factor Receptor-Associated Peptides and Proteins/physiology; Tumor Necrosis Factor-alpha/pharmacology; Two-Hybrid System Techniques |
edit table |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
involved_in |
GO:0010803: regulation of tumor necrosis factor-mediated signaling pathway |
ECO:0000315: mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
GO:1901224: positive regulation of NIK/NF-kappaB cascade |
ECO:0000314: |
P |
Fig 1.B Increased TNF signaling by Syk here demonstrates increased NF-kB activation. |
complete | ||||
GO:0006468: protein phosphorylation |
ECO:0000315: |
P |
1.B Syk phosphorylates TRIP. |
complete | ||||
GO:0006468: protein phosphorylation |
ECO:0000314: |
P |
Fig 1.C Syk phosphorylated TRIP. |
complete | ||||
Colocalizes with |
GO:0005737: cytoplasm |
ECO:0000314: |
C |
Figure 4c and D show that when SKY and TRIAP in Human breast cells MCF7 cells are coexpressed then both are found in the cytoplasm. This is not normal for SKY which is normally found throughout the cell. |
complete | |||
GO:0010803: regulation of tumor necrosis factor-mediated signaling pathway |
ECO:0000315: |
P |
SKY expression led to increased activity of the the TNF signaling pathway of resulting in activation of NF-kB as shown in Figure 5 particularly in C and D. Thus sky positively regulates TNF mediated signaling pathway. |
complete | ||||
involved_in |
GO:0010804: negative regulation of tumor necrosis factor-mediated signaling pathway |
ECO:0000314: direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
GO:0034504: protein localization to nucleus |
ECO:0000314: |
P |
figure 4A shows Trip colocalized into the nucleoli of the nucleus via immunoflorescence of MCF7 cells with overexpressed TRIP. |
complete | ||||
GO:0034504: protein localization to nucleus |
ECO:0000315: |
P |
Trip knockdown with siRNA in figure 4B leads to reduced TRIP in the nucleoli of the nucleus in MCF7 cells showing that when trip is being expressed it is localized in the nucleoli of the nucleus. |
complete | ||||
Colocalizes with |
GO:0005737: cytoplasm |
ECO:0000314: |
C |
Figure 4c and D shows when Sky-EGFP and TRIP were coexpressed then TRIP is colocalized along with SKY in the cytoplasm. |
complete | |||
GO:0010804: negative regulation of tumor necrosis factor-mediated signaling pathway |
ECO:0000314: |
P |
Increasing amounts of TRIP results in decreased activation of NF-kB by the TNF mediated pathway. This is indicated in Figure 6 and Supplemental figure 3. |
complete | ||||
See also
References
See Help:References for how to manage references in GONUTS.